Maxwell Biosciences Enters CRADA with USAMRIID to Test Potential Therapeutics Industry News May 8, 2024 …
Soligenix Extends Patent Protection for Filovirus Vaccine Platform to UK and South Africa Industry News April 25, 2024 …
Antiviral for Sudan Ebolavirus; Ebola Pathogenicity in Pigs; Repurposing SARS-CoV-2 Drugs for Marburg Pathogens April 3, 2024 …
Study on Ebola Vaccines and Boosting Regimen Contributes to Future Outbreak Preparedness Medical Countermeasures April 3, 2024 …
Primmune Therapeutics Awarded DTRA Funding for Lassa Fever Antiviral Medical Countermeasures March 20, 2024 …
How ProPublica Used Machine Learning to Investigate Where Ebola May Strike Biosurveillance August 8, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development Medical Countermeasures December 27, 2022 …
Stem Cell Research Gives New Clues on Ebola Virus Damage to Organs Medical Countermeasures September 9, 2022 …
Ebola Virus Can ‘Hide Out’ in the Brain After Treatment and Cause Recurrent Infections Pathogens March 15, 2022 …
Bucknell Researchers Head to Uganda to Study African Bats’ Immune Response to Ebola Virus Biosecurity February 6, 2022 …
U.S. Plans to Expand Regional Ebola and Other Special Pathogen Treatment Centers Contracts + Grants October 29, 2021 …
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines Contracts + Grants October 21, 2021 …
